Pfizer Inc
NYSE:PFE

Watchlist Manager
Pfizer Inc Logo
Pfizer Inc
NYSE:PFE
Watchlist
Price: 25.8 USD 0.08% Market Closed
Market Cap: 146.7B USD

EV/EBIT
Enterprise Value to EBIT

10.3
Current
10.4
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
10.3
=
Enterprise Value
189.2B USD
/
EBIT
18.3B USD
All Countries
Close
Market Cap EV/EBIT
US
Pfizer Inc
NYSE:PFE
146.7B USD 10.3
US
Eli Lilly and Co
NYSE:LLY
954.7B USD 37.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 17 702.3
US
Johnson & Johnson
NYSE:JNJ
505.3B USD 21.3
CH
Roche Holding AG
SIX:ROG
252.4B CHF 13.4
UK
AstraZeneca PLC
LSE:AZN
209.5B GBP 158.6
CH
Novartis AG
SIX:NOVN
203.3B CHF 14.6
US
Merck & Co Inc
NYSE:MRK
246.3B USD 11
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 11.2
IE
Endo International PLC
LSE:0Y5F
206B USD 818.8
FR
Sanofi SA
PAR:SAN
101.8B EUR 6.7
EBIT Growth EV/EBIT to Growth
US
Pfizer Inc
NYSE:PFE
Average EV/EBIT: 1 709.6
10.3
8%
1.3
US
Eli Lilly and Co
NYSE:LLY
37.3
36%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
21.3
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.4
5%
2.7
UK
AstraZeneca PLC
LSE:AZN
158.6
23%
6.9
CH
Novartis AG
SIX:NOVN
14.6
12%
1.2
US
Merck & Co Inc
NYSE:MRK
11
8%
1.4
DK
Novo Nordisk A/S
CSE:NOVO B
11.2
1%
11.2
IE
E
Endo International PLC
LSE:0Y5F
818.8
N/A N/A
FR
Sanofi SA
PAR:SAN
6.7
15%
0.4

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
hidden
2-Years Forward
EV/EBIT
hidden
3-Years Forward
EV/EBIT
hidden